MBIA (MBI) had the highest return between December 5, 2023 and December 11, 2023 by a small-cap US stock, returning 85.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
MBIA (MBI) | 12/5/2023 - 12/11/2023 | 85.48% |
Satellogic V (SATL) | 12/5/2023 - 12/11/2023 | 56.34% |
Pharvaris (PHVS) | 12/5/2023 - 12/11/2023 | 46.33% |
Arvinas (ARVN) | 12/5/2023 - 12/11/2023 | 41.36% |
Hovnanian Enterprises (HOV) | 12/5/2023 - 12/11/2023 | 40.99% |
Mercurity Fintech Holding Inc ADR (MFH) | 12/5/2023 - 12/11/2023 | 39.52% |
Innoviz Technologies (INVZ) | 12/5/2023 - 12/11/2023 | 32.18% |
Lands’ End (LE) | 12/5/2023 - 12/11/2023 | 31.99% |
Know Labs (KNW) | 12/5/2023 - 12/11/2023 | 30.37% |
Bitfarms (BITF) | 12/5/2023 - 12/11/2023 | 28.98% |
Sky Harbour (SKYH) | 12/5/2023 - 12/11/2023 | 27.18% |
DeFi Development (DFDV) | 12/5/2023 - 12/11/2023 | 25.02% |
Solid Biosciences LLC (SLDB) | 12/5/2023 - 12/11/2023 | 24.77% |
Porch (PRCH) | 12/5/2023 - 12/11/2023 | 24.71% |
Phreesia (PHR) | 12/5/2023 - 12/11/2023 | 24.65% |
Upexi (UPXI) | 12/5/2023 - 12/11/2023 | 22.89% |
Replimune (REPL) | 12/5/2023 - 12/11/2023 | 22.13% |
Tango Therapeutics (TNGX) | 12/5/2023 - 12/11/2023 | 21.09% |
IRSA Inversiones Y Representaciones (IRS) | 12/5/2023 - 12/11/2023 | 18.69% |
Grupo Supervielle (SUPV) | 12/5/2023 - 12/11/2023 | 18.68% |
Gyre Therapeutics (GYRE) | 12/5/2023 - 12/11/2023 | 18.56% |
Rigel Pharmaceuticals (RIGL) | 12/5/2023 - 12/11/2023 | 18.52% |
Equity Bancshares (EQBK) | 12/5/2023 - 12/11/2023 | 18.23% |
Organogenesis (ORGO) | 12/5/2023 - 12/11/2023 | 17.88% |
Travere Therapeutics (TVTX) | 12/5/2023 - 12/11/2023 | 17.82% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
